Discovery Could Advance Treatment for Alzheimer's, Immune Diseases, Weill Cornell Team Says
Researchers at Weill Cornell Medical College have gotten much closer to understanding how immune-based therapies can treat Alzheimer's disease — by studying how antibodies go inside brain cells to reduce levels of Alzheimer's-linked amyloid peptides that form plaques between neurons.
"This internalization and activity of the antibody within the cell was a big surprise and something we really haven't appreciated in neurological medicine. It gives us new hope for the use of immunotherapy against Alzheimer's, while casting intriguing new light on other disease processes," says senior author Dr. Gunnar Gouras, associate professor of neurology and neuroscience at Weill Cornell Medical College and associate attending neurologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
His team's study will appear as a prestigious "paper of the week" in an upcoming issue of the Journal of Biological Chemistry, and was published in the May 1 online edition of the journal.
Read the original source material and the article in its entirity at the Weill Cornell Medical W
Researchers at Weill Cornell Medical College have gotten much closer to understanding how immune-based therapies can treat Alzheimer's disease — by studying how antibodies go inside brain cells to reduce levels of Alzheimer's-linked amyloid peptides that form plaques between neurons.
"This internalization and activity of the antibody within the cell was a big surprise and something we really haven't appreciated in neurological medicine. It gives us new hope for the use of immunotherapy against Alzheimer's, while casting intriguing new light on other disease processes," says senior author Dr. Gunnar Gouras, associate professor of neurology and neuroscience at Weill Cornell Medical College and associate attending neurologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
His team's study will appear as a prestigious "paper of the week" in an upcoming issue of the Journal of Biological Chemistry, and was published in the May 1 online edition of the journal.
Read the original source material and the article in its entirity at the Weill Cornell Medical W
Subscribe to The Alzheimer's Reading Room--via Email
Popular articles on the Alzheimer's Reading Room
- Worried About Alzheimer's Disease
- Dementia and the Eight Types of Dementia
- H1N1 Flu Virus Everything You Need to Know
- Does the Combination of Aricept and Namenda Help Slow the Rate of Decline in Alzheimer's Patients
- Test Your Memory (TYM) for Alzheimer's or Dementia in Five Minutes
- Dimebon Connection Study
- The Metamorphosis of This Alzheimer's Caregiver (Part One)
- The Mini-Cog Test for Alzheimer's and Dementia
- Worried about Alzheimer's? Five Ways to Protect Yourself
- Is it Really Alzheimer's or Something Else?
- Alzheimer's Wandering Why it Happens and What to Do
- 50 Good Reasons to Subscribe to the Alzheimer's Reading Room Now
- World Health Care Spending and Performance Ranking by Country (Table)
- Urinary Incontinence -- How We Beat Alzheimer's Incontinence
- Are Alzheimer's Caregivers the Forgotten?
- A Simple Three Minute Test Can Detect the Earliest Stage of Alzheimer's Disease
- Wii a Useful Tool for Alzheimer's Caregivers
- 2009 Alzheimer's Disease Facts and Figures
Bob DeMarco is the editor of the Alzheimer's Reading Room and an Alzheimer's caregiver. The Alzheimer's Reading Room is the number one website on the Internet for news, advice, and insight into Alzheimer's disease. Bob has written more than 950 articles with more than 8,000 links on the Internet. Bob resides in Delray Beach, FL.
Original content Bob DeMarco, Alzheimer's Reading Room
